ARTICLE | Company News
DTLL Inc., GelStat deal
January 10, 2005 8:00 AM UTC
GSAC's GS Pharma unit merged with shell company DTLI in a $35 million stock deal. GSAC now owns 94% of DTLI, which will change its name to GS Pharma. GS plans to develop therapeutics to treat arthriti...